about
Tilapia hepcidin 2-3 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4DEnhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice.Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2.Applications of antimicrobial peptides from fish and perspectives for the future.A cancer vaccine based on the marine antimicrobial peptide pardaxin (GE33) for control of bladder-associated tumors.Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5.Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine.Tilapia (Oreochromis mossambicus) antimicrobial peptide, hepcidin 1-5, shows antitumor activity in cancer cells.The antimicrobial peptide, tilapia hepcidin 2-3, and PMA differentially regulate the protein kinase C isoforms, TNF-α and COX-2, in mouse RAW264.7 macrophages.Transcriptome analysis of medaka following epinecidin-1 and TH1-5 treatment of NNV infection.Evaluation of the epinecidin-1 peptide as an active ingredient in cleaning solutions against pathogens.Insights into the antibacterial and immunomodulatory functions of tilapia hepcidin (TH)2-3 against Vibrio vulnificus infection in miceUse of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuriesDietary supplementation of recombinant antimicrobial peptide Epinephelus lanceolatus piscidin improves growth performance and immune response in Gallus gallus domesticus
P50
Q34155303-DD7AFB8F-6BC1-4FE5-9923-4D2FD61147EDQ35657546-F7FF31FC-FF2D-4A41-9A1D-B34EB61F6ABEQ36016622-A605B045-614D-434B-B1D0-8CA8370389DFQ37811195-5D0ACAF7-EE0D-41FE-B301-8F184D329D21Q39090419-8928E1EE-8288-4385-9C0B-8B2A0A70997AQ39512925-EFB5554F-75CA-4732-9EF4-18E50D47C79EQ39593279-5BE85929-04C1-4A6E-A351-C0BE3B96DC40Q39629433-B3B9251E-0607-4B33-A758-28149C5BF6F7Q39629438-04B734A0-39E6-443D-A60E-4D43897BC924Q41633954-2F4141D2-B2A3-4E37-959E-DAC2E3607DA0Q54383695-626F1BD8-9E81-46F7-B7F5-673B29349D39Q84560373-8DBA476E-1F2D-43CB-9935-04C298CD2405Q86054864-7EA3D1B0-1EF5-4DC1-AD42-F1F6FB331717Q90236630-E6691C2A-451C-4D99-97ED-D40501AD2C25
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Venugopal Rajanbabu
@en
Venugopal Rajanbabu
@nl
type
label
Venugopal Rajanbabu
@en
Venugopal Rajanbabu
@nl
prefLabel
Venugopal Rajanbabu
@en
Venugopal Rajanbabu
@nl
P31
P496
0000-0001-8761-3333